Reviva Pharmaceuticals Holdings, Inc. (RVPH)
0.7709
-0.07
(-8.77%)
USD |
NASDAQ |
Apr 10, 16:00
0.7863
+0.02
(+2.00%)
After-Hours: 20:00
Reviva Pharmaceuticals Holdings Shareholders Equity (Quarterly) : 8.648M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| AbbVie, Inc. | -3.27B |
| Bristol Myers Squibb Co. | 18.47B |
| ACADIA Pharmaceuticals, Inc. | 1.227B |
| Alnylam Pharmaceuticals, Inc. | 789.18M |
| Savara, Inc. | 203.13M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 15.92M |
| Total Liabilities (Quarterly) | 7.276M |
| Debt to Equity Ratio | 0.0471 |
| Current Ratio | 2.076 |
| Net Debt Paydown Yield | -0.20% |